These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 26664665)

  • 1. CD49d is a disease progression biomarker and a potential target for immunotherapy in Duchenne muscular dystrophy.
    Pinto-Mariz F; Rodrigues Carvalho L; Prufer De Queiroz Campos Araujo A; De Mello W; Gonçalves Ribeiro M; Cunha Mdo C; Cabello PH; Riederer I; Negroni E; Desguerre I; Veras M; Yada E; Allenbach Y; Benveniste O; Voit T; Mouly V; Silva-Barbosa SD; Butler-Browne G; Savino W
    Skelet Muscle; 2015; 5():45. PubMed ID: 26664665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flow Cytometry-Defined CD49d Expression in Circulating T-Lymphocytes Is a Biomarker for Disease Progression in Duchenne Muscular Dystrophy.
    Savino W; Pinto-Mariz F; Mouly V
    Methods Mol Biol; 2018; 1687():219-227. PubMed ID: 29067667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive markers of clinical outcome in the GRMD dog model of Duchenne muscular dystrophy.
    Barthélémy I; Pinto-Mariz F; Yada E; Desquilbet L; Savino W; Silva-Barbosa SD; Faussat AM; Mouly V; Voit T; Blot S; Butler-Browne G
    Dis Model Mech; 2014 Nov; 7(11):1253-61. PubMed ID: 25261568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum miR-206 and other muscle-specific microRNAs as non-invasive biomarkers for Duchenne muscular dystrophy.
    Hu J; Kong M; Ye Y; Hong S; Cheng L; Jiang L
    J Neurochem; 2014 Jun; 129(5):877-83. PubMed ID: 24460924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased Number of Circulating CD8/CD26 T Cells in the Blood of Duchenne Muscular Dystrophy Patients Is Associated with Augmented Binding of Adenosine Deaminase and Higher Muscular Strength Scores.
    Soslow JH; Markham LW; Burnette WB; Galindo CL; Feoktistov I; Raucci FJ; Damon BM; Sawyer DB; Ryzhov S
    Front Pharmacol; 2017; 8():914. PubMed ID: 29326589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Therapy of Duchenne muscular dystrophy with umbilical cord blood stem cell transplantation].
    Zhang C; Feng HY; Huang SL; Fang JP; Xiao LL; Yao XL; Chen C; Ye X; Zeng Y; Lu XL; Wen JM; Zhang WX; Li Z; Feng SW; Xu HG; Huang K; Zhou DH; Chen W; Xie YM; Xi J; Zhang M; Li Y; Liu Y
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Aug; 22(4):399-405. PubMed ID: 16086277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Spotlight on T Lymphocytes in Duchenne Muscular Dystrophy-Not Just a Muscle Defect.
    Coles CA; Woodcock I; Pellicci DG; Houweling PJ
    Biomedicines; 2022 Feb; 10(3):. PubMed ID: 35327337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteomics profiling of urine reveals specific titin fragments as biomarkers of Duchenne muscular dystrophy.
    Rouillon J; Zocevic A; Leger T; Garcia C; Camadro JM; Udd B; Wong B; Servais L; Voit T; Svinartchouk F
    Neuromuscul Disord; 2014 Jul; 24(7):563-73. PubMed ID: 24813925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The value of mammalian models for duchenne muscular dystrophy in developing therapeutic strategies.
    Banks GB; Chamberlain JS
    Curr Top Dev Biol; 2008; 84():431-53. PubMed ID: 19186250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. P2RX7 purinoceptor: a therapeutic target for ameliorating the symptoms of duchenne muscular dystrophy.
    Sinadinos A; Young CN; Al-Khalidi R; Teti A; Kalinski P; Mohamad S; Floriot L; Henry T; Tozzi G; Jiang T; Wurtz O; Lefebvre A; Shugay M; Tong J; Vaudry D; Arkle S; doRego JC; Górecki DC
    PLoS Med; 2015 Oct; 12(10):e1001888. PubMed ID: 26461208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.
    Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS
    Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Detection of new mutations in the dystrophin gene by denaturing high-performance liquid chromatography].
    Chen YN; Zhou X; Jin CL; Xu Y; Lin CK; Cao LH; Li N; Zhang X; Luo Y
    Zhonghua Er Ke Za Zhi; 2007 Jun; 45(6):413-6. PubMed ID: 17880784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new model mouse for Duchenne muscular dystrophy produced by 2.4 Mb deletion of dystrophin gene using Cre-loxP recombination system.
    Kudoh H; Ikeda H; Kakitani M; Ueda A; Hayasaka M; Tomizuka K; Hanaoka K
    Biochem Biophys Res Commun; 2005 Mar; 328(2):507-16. PubMed ID: 15694376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of Induced Pluripotent Stem Cells From Patients With Duchenne Muscular Dystrophy and Their Induction to Cardiomyocytes.
    Hashimoto A; Naito AT; Lee JK; Kitazume-Taneike R; Ito M; Yamaguchi T; Nakata R; Sumida T; Okada K; Nakagawa A; Higo T; Kuramoto Y; Sakai T; Tominaga K; Okinaga T; Kogaki S; Ozono K; Miyagawa S; Sawa Y; Sakata Y; Morita H; Umezawa A; Komuro I
    Int Heart J; 2016; 57(1):112-7. PubMed ID: 26673445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Large-scale serum protein biomarker discovery in Duchenne muscular dystrophy.
    Hathout Y; Brody E; Clemens PR; Cripe L; DeLisle RK; Furlong P; Gordish-Dressman H; Hache L; Henricson E; Hoffman EP; Kobayashi YM; Lorts A; Mah JK; McDonald C; Mehler B; Nelson S; Nikrad M; Singer B; Steele F; Sterling D; Sweeney HL; Williams S; Gold L
    Proc Natl Acad Sci U S A; 2015 Jun; 112(23):7153-8. PubMed ID: 26039989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Correlation between genotypes and phenotypes in pseudohypertrophic muscular dystrophy].
    Feng SW; Liang YY; Cao JQ; Song XM; Zhang C
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2012 Dec; 29(6):653-7. PubMed ID: 23225043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A reporter mouse for optical imaging of inflammation in mdx muscles.
    Martinez L; Ermolova NV; Ishikawa TO; Stout DB; Herschman HR; Spencer MJ
    Skelet Muscle; 2015; 5():15. PubMed ID: 25949789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deletion mutations in the dystrophin gene of Saudi patients with Duchenne and Becker muscular dystrophy.
    Al-Jumah M; Majumdar R; Al-Rajeh S; Chaves-Carballo E; Salih MM; Awada A; Al-Shahwan S; Al-Uthaim S
    Saudi Med J; 2002 Dec; 23(12):1478-82. PubMed ID: 12518196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolving therapeutic strategies for Duchenne muscular dystrophy: targeting downstream events.
    Tidball JG; Wehling-Henricks M
    Pediatr Res; 2004 Dec; 56(6):831-41. PubMed ID: 15531741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Immune System in Duchenne Muscular Dystrophy Pathogenesis.
    Tripodi L; Villa C; Molinaro D; Torrente Y; Farini A
    Biomedicines; 2021 Oct; 9(10):. PubMed ID: 34680564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.